Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6661 | 1384 | 43.0 | 84% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
157 | 21931 | BENIGN PROSTATIC HYPERPLASIA//PROSTATE CANCER//PROSTATE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LZTS1 | Author keyword | 11 | 69% | 1% | 9 |
2 | UROGENE | Address | 4 | 75% | 0% | 3 |
3 | NUCLEAR ROUNDNESS | Author keyword | 3 | 100% | 0% | 3 |
4 | METASTASIS SUPPRESSOR GENES | Author keyword | 3 | 33% | 1% | 7 |
5 | OSPED SANTO ANDREA | Address | 2 | 38% | 0% | 5 |
6 | CLINICAL PROSTATE CANCER | Author keyword | 2 | 67% | 0% | 2 |
7 | NUCLEAR ROUNDNESS FACTOR | Author keyword | 2 | 67% | 0% | 2 |
8 | RNA SSCP ANALYSIS | Author keyword | 2 | 67% | 0% | 2 |
9 | CHROMOSOME 8P | Author keyword | 2 | 23% | 1% | 8 |
10 | EA3104 | Address | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LZTS1 | 11 | 69% | 1% | 9 | Search LZTS1 | Search LZTS1 |
2 | NUCLEAR ROUNDNESS | 3 | 100% | 0% | 3 | Search NUCLEAR+ROUNDNESS | Search NUCLEAR+ROUNDNESS |
3 | METASTASIS SUPPRESSOR GENES | 3 | 33% | 1% | 7 | Search METASTASIS+SUPPRESSOR+GENES | Search METASTASIS+SUPPRESSOR+GENES |
4 | CLINICAL PROSTATE CANCER | 2 | 67% | 0% | 2 | Search CLINICAL+PROSTATE+CANCER | Search CLINICAL+PROSTATE+CANCER |
5 | NUCLEAR ROUNDNESS FACTOR | 2 | 67% | 0% | 2 | Search NUCLEAR+ROUNDNESS+FACTOR | Search NUCLEAR+ROUNDNESS+FACTOR |
6 | RNA SSCP ANALYSIS | 2 | 67% | 0% | 2 | Search RNA+SSCP+ANALYSIS | Search RNA+SSCP+ANALYSIS |
7 | CHROMOSOME 8P | 2 | 23% | 1% | 8 | Search CHROMOSOME+8P | Search CHROMOSOME+8P |
8 | EIF3S3 | 1 | 100% | 0% | 2 | Search EIF3S3 | Search EIF3S3 |
9 | IN SITU APOPTOSIS | 1 | 50% | 0% | 2 | Search IN+SITU+APOPTOSIS | Search IN+SITU+APOPTOSIS |
10 | PAB 240 | 1 | 50% | 0% | 2 | Search PAB+240 | Search PAB+240 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALLELIC LOSS | 31 | 13% | 16% | 222 |
2 | CHROMOSOME 8P22 | 29 | 88% | 1% | 14 |
3 | DEOXYRIBONUCLEIC ACID PLOIDY | 18 | 41% | 2% | 33 |
4 | ROUNDNESS FACTOR MEASUREMENT | 17 | 62% | 1% | 18 |
5 | FEZ1 LZTS1 GENE | 13 | 80% | 1% | 8 |
6 | MYC PROTOONCOGENE | 9 | 45% | 1% | 15 |
7 | DNA PLOIDY ANALYSIS | 8 | 41% | 1% | 16 |
8 | MODAL DEOXYRIBONUCLEIC ACID | 7 | 67% | 0% | 6 |
9 | MARKERS P53 | 6 | 80% | 0% | 4 |
10 | DIAGNOSTIC NEEDLE BIOPSIES | 4 | 67% | 0% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Chromosomal deletions and tumor suppressor genes in prostate cancer | 2001 | 130 | 202 | 63% |
Molecular genetics of prostate cancer | 2000 | 368 | 281 | 30% |
Chromosomal clues to the development of prostate tumors | 1999 | 63 | 77 | 74% |
Chromosomal basis of adenocarcinoma of the prostate | 1999 | 54 | 105 | 81% |
Cell lines used in prostate cancer research: A compendium of old and new lines - Part 1 | 2005 | 141 | 82 | 23% |
Molecular markers of prostate cancer outcome | 2005 | 120 | 402 | 24% |
Fez1/Lzts1 a new mitotic regulator implicated in cancer development | 2007 | 9 | 17 | 71% |
Cell lines used in prostate cancer research: A compendium of old and new lines - Part 2 | 2005 | 63 | 71 | 30% |
Human prostate cancer risk factors | 2004 | 224 | 1413 | 12% |
Molecular genetics and epidemiology of prostate carcinoma | 1999 | 115 | 265 | 26% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UROGENE | 4 | 75% | 0.2% | 3 |
2 | OSPED SANTO ANDREA | 2 | 38% | 0.4% | 5 |
3 | EA3104 | 1 | 50% | 0.1% | 2 |
4 | MOL ONCOL M7 | 1 | 100% | 0.1% | 2 |
5 | PATHOL COMPAN ANIM | 1 | 100% | 0.1% | 2 |
6 | HUMAN CANC GENET UNIT | 1 | 27% | 0.3% | 4 |
7 | CANC SERV DIRECTORATE | 1 | 40% | 0.1% | 2 |
8 | HUMAN HERED | 1 | 40% | 0.1% | 2 |
9 | CELLULAR PATHOL MOL GENET | 1 | 19% | 0.3% | 4 |
10 | CLIN UROL PEDIAT UROL | 1 | 12% | 0.4% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000163370 | NKX31//LOBUND//3 2 DIMETHYL 4 AMINOBIPHENYL |
2 | 0.0000139865 | EBP1//RADIOBIOL CANC//PA2G4 |
3 | 0.0000130853 | PROSTATIC INTRAEPITHELIAL NEOPLASIA//ATYPICAL SMALL ACINAR PROLIFERATION//ALPHA METHYLACYL COA RACEMASE |
4 | 0.0000115749 | LIFESPAN MED//CYTOGENET FISH GENOTOXICOL//BUCCAL SMEARS |
5 | 0.0000100575 | PCA3//TMPRSS2 ERG//PROSTATE CANCER ANTIGEN 3 |
6 | 0.0000087651 | RNASEL//HEREDITARY PROSTATE CANCER//8Q24 |
7 | 0.0000085760 | CLIN BREAST CARE PROJECT//16Q243//CHROMOSOMAL SCANNING |
8 | 0.0000082668 | PROSTATE US STUDIES//INCIDENTAL PROSTATE CANCER//TRANSRECTAL ULTRASOUND |
9 | 0.0000078778 | PROSTATE DEVELOPMENT//BIOL SCI VET MED//PROSTATE STEM CELL |
10 | 0.0000075483 | RADICAL PROSTATECTOMY//PROSTATECTOMY//SALVAGE RADIOTHERAPY |